Lacey David L. 4
4 · Unity Biotechnology, Inc. · Filed Jun 22, 2020
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-18+25,000→ 25,000 totalExercise: $9.14Exp: 2030-06-17→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 18, 2020 or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.